Cargando…

Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models

OBJECTIVE: To correct cervical cancer mortality rates for death cause certification problems in Belgium and to describe the corrected trends (1954-1997) using Bayesian models. METHOD: Cervical cancer (cervix uteri (CVX), corpus uteri (CRP), not otherwise specified (NOS) uterus cancer and other very...

Descripción completa

Detalles Bibliográficos
Autores principales: Raifu, AO, Arbyn, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463015/
http://dx.doi.org/10.1186/0778-7367-67-3-100
_version_ 1782245239545659392
author Raifu, AO
Arbyn, M
author_facet Raifu, AO
Arbyn, M
author_sort Raifu, AO
collection PubMed
description OBJECTIVE: To correct cervical cancer mortality rates for death cause certification problems in Belgium and to describe the corrected trends (1954-1997) using Bayesian models. METHOD: Cervical cancer (cervix uteri (CVX), corpus uteri (CRP), not otherwise specified (NOS) uterus cancer and other very rare uterus cancer (OTH) mortality data were extracted from the WHO mortality database together with population data for Belgium and the Netherlands. Different ICD (International Classification of Diseases) were used over time for death cause certification. In the Netherlands, the proportion of not-otherwise specified uterine cancer deaths was small over large periods and therefore internal reallocation could be used to estimate the corrected rates cervical cancer mortality. In Belgium, the proportion of improperly defined uterus deaths was high. Therefore, the age-specific proportions of uterus cancer deaths that are probably of cervical origin for the Netherlands was applied to Belgian uterus cancer deaths to estimate the corrected number of cervix cancer deaths (corCVX). A Bayesian loglinear Poisson-regression model was performed to disentangle the separate effects of age, period and cohort. RESULTS: The corrected age standardized mortality rate (ASMR) decreased regularly from 9.2/100 000 in the mid 1950s to 2.5/100,000 in the late 1990s. Inclusion of age, period and cohort into the models were required to obtain an adequate fit. Cervical cancer mortality increases with age, declines over calendar period and varied irregularly by cohort. CONCLUSION: Mortality increased with ageing and declined over time in most age-groups, but varied irregularly by birth cohort. In global, with some discrete exceptions, mortality decreased for successive generations up to the cohorts born in the 1930s. This decline stopped for cohorts born in the 1940s and thereafter. For the youngest cohorts, even a tendency of increasing risk of dying from cervical cancer could be observed, reflecting increased exposure to risk factors. The fact that this increase was limited for the youngest cohorts could be explained as an effect of screening. Bayesian modeling provided similar results compared to previously used classical Poisson models. However, Bayesian models are more robust for estimating rates when data are sparse (youngest age groups, most recent cohorts) and can be used to for predicting future trends.
format Online
Article
Text
id pubmed-3463015
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34630152012-10-05 Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models Raifu, AO Arbyn, M Arch Public Health Research OBJECTIVE: To correct cervical cancer mortality rates for death cause certification problems in Belgium and to describe the corrected trends (1954-1997) using Bayesian models. METHOD: Cervical cancer (cervix uteri (CVX), corpus uteri (CRP), not otherwise specified (NOS) uterus cancer and other very rare uterus cancer (OTH) mortality data were extracted from the WHO mortality database together with population data for Belgium and the Netherlands. Different ICD (International Classification of Diseases) were used over time for death cause certification. In the Netherlands, the proportion of not-otherwise specified uterine cancer deaths was small over large periods and therefore internal reallocation could be used to estimate the corrected rates cervical cancer mortality. In Belgium, the proportion of improperly defined uterus deaths was high. Therefore, the age-specific proportions of uterus cancer deaths that are probably of cervical origin for the Netherlands was applied to Belgian uterus cancer deaths to estimate the corrected number of cervix cancer deaths (corCVX). A Bayesian loglinear Poisson-regression model was performed to disentangle the separate effects of age, period and cohort. RESULTS: The corrected age standardized mortality rate (ASMR) decreased regularly from 9.2/100 000 in the mid 1950s to 2.5/100,000 in the late 1990s. Inclusion of age, period and cohort into the models were required to obtain an adequate fit. Cervical cancer mortality increases with age, declines over calendar period and varied irregularly by cohort. CONCLUSION: Mortality increased with ageing and declined over time in most age-groups, but varied irregularly by birth cohort. In global, with some discrete exceptions, mortality decreased for successive generations up to the cohorts born in the 1930s. This decline stopped for cohorts born in the 1940s and thereafter. For the youngest cohorts, even a tendency of increasing risk of dying from cervical cancer could be observed, reflecting increased exposure to risk factors. The fact that this increase was limited for the youngest cohorts could be explained as an effect of screening. Bayesian modeling provided similar results compared to previously used classical Poisson models. However, Bayesian models are more robust for estimating rates when data are sparse (youngest age groups, most recent cohorts) and can be used to for predicting future trends. BioMed Central 2009-11-27 /pmc/articles/PMC3463015/ http://dx.doi.org/10.1186/0778-7367-67-3-100 Text en Copyright ©2009 Raifu and Arbyn
spellingShingle Research
Raifu, AO
Arbyn, M
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title_full Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title_fullStr Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title_full_unstemmed Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title_short Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models
title_sort description of cervical cancer mortality in belgium using bayesian age-period-cohort models
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463015/
http://dx.doi.org/10.1186/0778-7367-67-3-100
work_keys_str_mv AT raifuao descriptionofcervicalcancermortalityinbelgiumusingbayesianageperiodcohortmodels
AT arbynm descriptionofcervicalcancermortalityinbelgiumusingbayesianageperiodcohortmodels